Advocacy intelligence hub — real-time data for patient organizations
ViiV Healthcare — PHASE2
Jiangsu Aidea Pharmaceutical Group Co., Ltd. — PHASE1, PHASE2
ViiV Healthcare — PHASE2
Gilead Sciences — PHASE2
National Institute of Allergy and Infectious Diseases (NIAID) — PHASE1
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Christine Katlama, MD
Groupe Hospitalier Pitié-Salpêtrière
Diane Havlir, MD
📍 SAN FRANCISCO, CA
Jade Ghosn, MD
Centre Hsopitalier Universitaire de Bicêtre
Francois Venter, FCP (SA)
Wits Reproductive Health & HIV Institute
Martin Markowitz
📍 NEW YORK, NY
Susan Little
View all Syndrome with combined immunodeficiency specialists →